Brandywine Oak Private Wealth LLC Has $401,000 Stake in The Chemours Company (NYSE:CC)

Brandywine Oak Private Wealth LLC lowered its stake in The Chemours Company (NYSE:CCFree Report) by 4.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 23,741 shares of the specialty chemicals company’s stock after selling 1,075 shares during the period. Brandywine Oak Private Wealth LLC’s holdings in Chemours were worth $401,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Matrix Trust Co acquired a new stake in shares of Chemours during the 3rd quarter worth approximately $25,000. Blue Trust Inc. boosted its position in shares of Chemours by 166.9% during the 3rd quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 731 shares in the last quarter. GAMMA Investing LLC increased its stake in Chemours by 99.7% in the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock valued at $26,000 after acquiring an additional 765 shares during the period. Truvestments Capital LLC acquired a new position in Chemours in the third quarter worth about $35,000. Finally, Brooklyn Investment Group bought a new position in Chemours during the third quarter worth about $37,000. Institutional investors own 76.26% of the company’s stock.

Analyst Upgrades and Downgrades

CC has been the topic of several analyst reports. The Goldman Sachs Group lowered their price objective on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Royal Bank of Canada restated an “outperform” rating and issued a $25.00 target price on shares of Chemours in a research note on Thursday, December 12th. Truist Financial started coverage on shares of Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 target price for the company. Mizuho reduced their price target on shares of Chemours from $22.00 to $21.00 and set a “neutral” rating on the stock in a research report on Tuesday, January 7th. Finally, Morgan Stanley dropped their price objective on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating for the company in a report on Monday, January 13th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $24.11.

Read Our Latest Analysis on Chemours

Chemours Stock Performance

NYSE:CC opened at $18.67 on Thursday. The firm has a market capitalization of $2.79 billion, a PE ratio of 37.33 and a beta of 1.81. The company has a quick ratio of 0.92, a current ratio of 1.73 and a debt-to-equity ratio of 6.05. The Chemours Company has a twelve month low of $15.10 and a twelve month high of $31.76. The stock’s 50-day simple moving average is $18.89 and its 200 day simple moving average is $19.35.

Chemours (NYSE:CCGet Free Report) last issued its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.08. The company had revenue of $1.50 billion during the quarter, compared to the consensus estimate of $1.44 billion. Chemours had a return on equity of 29.48% and a net margin of 1.34%. The firm’s revenue was up .9% compared to the same quarter last year. During the same period last year, the company earned $0.64 earnings per share. On average, analysts anticipate that The Chemours Company will post 1.21 EPS for the current fiscal year.

About Chemours

(Free Report)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

Further Reading

Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CCFree Report).

Institutional Ownership by Quarter for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.